Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon L Phillips

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphomaSughosh Dhakal, Tithi Biswas, Jane L Liesveld, et al.
American Journal of Hematology|May 11, 2012
Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopeniaRobin Reid, John M Bennett, Michael Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years laterHillard M Lazarus, Gordon L Phillips, Roger H Herzig, et al.
Leukemia Research|October 1, 2013
A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemiaDianna S Howard, Jane Liesveld, Gordon L Phillips, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphomaTithi Biswas, Eva Culakova, Jonathan W Friedberg, et al.
Cancer Investigation|July 12, 2011
Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell linesJane L Liesveld, Karen E Rosell, Jeremy Bechelli, et al.
Cancer Medicine|October 5, 2016
Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effectiveRobin M Reid, Andrea Baran, Jonathan W Friedberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2015
The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic ReviewHafsa M Chaudhry, Alison J Bruce, Robert C Wolf, et al.
Leukemia Research|October 22, 2013
A phase I study of decitabine and rapamycin in relapsed/refractory AMLJane L Liesveld, Kristen O'Dwyer, Alison Walker, et al.
Bone Marrow Transplantation|June 17, 2018
Final outcomes of escalated melphalan 280 mg/m<sup>2</sup> with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survivalParameswaran Hari, Donna E Reece, Jasleen Randhawa, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphomaSughosh Dhakal, Tithi Biswas, Jane L Liesveld, et al.
American Journal of Hematology|May 11, 2012
Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopeniaRobin Reid, John M Bennett, Michael Becker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years laterHillard M Lazarus, Gordon L Phillips, Roger H Herzig, et al.
Leukemia Research|October 1, 2013
A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemiaDianna S Howard, Jane Liesveld, Gordon L Phillips, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphomaTithi Biswas, Eva Culakova, Jonathan W Friedberg, et al.
Cancer Investigation|July 12, 2011
Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell linesJane L Liesveld, Karen E Rosell, Jeremy Bechelli, et al.
Cancer Medicine|October 5, 2016
Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effectiveRobin M Reid, Andrea Baran, Jonathan W Friedberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2015
The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic ReviewHafsa M Chaudhry, Alison J Bruce, Robert C Wolf, et al.
Leukemia Research|October 22, 2013
A phase I study of decitabine and rapamycin in relapsed/refractory AMLJane L Liesveld, Kristen O'Dwyer, Alison Walker, et al.
Bone Marrow Transplantation|June 17, 2018
Final outcomes of escalated melphalan 280 mg/m<sup>2</sup> with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survivalParameswaran Hari, Donna E Reece, Jasleen Randhawa, et al.
Pageof 4